MX9304133A - Nuevos derivados de los fosfolipidos. - Google Patents

Nuevos derivados de los fosfolipidos.

Info

Publication number
MX9304133A
MX9304133A MX9304133A MX9304133A MX9304133A MX 9304133 A MX9304133 A MX 9304133A MX 9304133 A MX9304133 A MX 9304133A MX 9304133 A MX9304133 A MX 9304133A MX 9304133 A MX9304133 A MX 9304133A
Authority
MX
Mexico
Prior art keywords
phospholipids
new derivatives
derivatives
new
medicaments
Prior art date
Application number
MX9304133A
Other languages
English (en)
Inventor
Wolfgang Schumacher
Jurij Stekar
Peter Hilgard
Gerhard Nossner
Bernhard Kutscher
Jungen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of MX9304133A publication Critical patent/MX9304133A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describen nuevos derivados de los fosfolípidos, su procedimiento de elaboración y su aplicación como medicamento.
MX9304133A 1992-07-11 1993-07-09 Nuevos derivados de los fosfolipidos. MX9304133A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (de) 1992-07-11 1992-07-11 Neue Phospholipidderivate

Publications (1)

Publication Number Publication Date
MX9304133A true MX9304133A (es) 1994-04-29

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304133A MX9304133A (es) 1992-07-11 1993-07-09 Nuevos derivados de los fosfolipidos.

Country Status (31)

Country Link
EP (1) EP0579939B1 (es)
JP (1) JP3311431B2 (es)
KR (1) KR100297180B1 (es)
CN (1) CN1039012C (es)
AT (1) ATE176477T1 (es)
AU (1) AU664101B2 (es)
BR (1) BR9302809A (es)
CA (2) CA2100228C (es)
CZ (1) CZ290863B6 (es)
DE (2) DE4222910A1 (es)
DK (1) DK0579939T3 (es)
EE (1) EE03140B1 (es)
ES (1) ES2129053T3 (es)
FI (1) FI111262B (es)
GR (1) GR3029602T3 (es)
HR (1) HRP931046B1 (es)
HU (1) HU218783B (es)
IL (1) IL106289A (es)
LT (1) LT3113B (es)
LV (1) LV10870B (es)
MX (1) MX9304133A (es)
NO (1) NO306468B1 (es)
PL (3) PL175607B1 (es)
RU (1) RU2108336C1 (es)
SG (1) SG46249A1 (es)
SI (1) SI9300365B (es)
SK (1) SK283827B6 (es)
TW (1) TW304956B (es)
UA (1) UA40567C2 (es)
YU (1) YU49079B (es)
ZA (1) ZA934971B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077424A1 (en) 2005-01-21 2006-07-27 Astex Therapeutics Limited Pharmaceutical compounds
AR058397A1 (es) * 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
DE3765502D1 (de) * 1986-07-14 1990-11-15 Nippon Chemiphar Co Glycerolderivat und antihypertensives mittel.
ES2058260T3 (es) * 1987-03-24 1994-11-01 Nippon Chemiphar Co Un proceso para la preparacion de un derivado del glicerol.
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
FI111262B (fi) 2003-06-30
AU4186493A (en) 1994-01-13
DK0579939T3 (da) 1999-09-20
LV10870A (lv) 1995-10-20
CN1084175A (zh) 1994-03-23
HUT64548A (en) 1994-01-28
ES2129053T3 (es) 1999-06-01
HU218783B (hu) 2000-12-28
NO306468B1 (no) 1999-11-08
GR3029602T3 (en) 1999-06-30
NO932502D0 (no) 1993-07-08
SK67093A3 (en) 1995-03-08
EP0579939A1 (de) 1994-01-26
IL106289A (en) 2000-06-01
KR100297180B1 (ko) 2001-11-30
PL175607B1 (pl) 1999-01-29
TW304956B (es) 1997-05-11
LV10870B (en) 1996-06-20
FI933165A0 (fi) 1993-07-09
NO932502L (no) 1994-01-12
LTIP620A (en) 1994-07-15
CZ124993A3 (en) 1995-03-15
DE59309355D1 (de) 1999-03-18
EE03140B1 (et) 1998-12-15
HRP931046A2 (en) 1997-04-30
CA2100228C (en) 2006-01-24
ATE176477T1 (de) 1999-02-15
CA2511753A1 (en) 1994-01-12
YU49079B (sh) 2003-08-29
IL106289A0 (en) 1994-04-12
PL173388B1 (pl) 1998-02-27
UA40567C2 (uk) 2001-08-15
HRP931046B1 (en) 2000-06-30
ZA934971B (en) 1994-02-01
SI9300365A (en) 1994-03-31
KR940002265A (ko) 1994-02-17
JP3311431B2 (ja) 2002-08-05
SK283827B6 (sk) 2004-02-03
CZ290863B6 (cs) 2002-11-13
HU9301992D0 (en) 1993-09-28
RU2108336C1 (ru) 1998-04-10
CN1039012C (zh) 1998-07-08
PL299624A1 (en) 1994-02-21
AU664101B2 (en) 1995-11-02
BR9302809A (pt) 1994-03-15
CA2100228A1 (en) 1994-01-12
FI933165A (fi) 1994-01-12
YU47393A (sh) 1997-08-22
DE4222910A1 (de) 1994-01-13
CA2511753C (en) 2007-09-25
LT3113B (en) 1994-12-27
SG46249A1 (en) 1998-02-20
PL177811B1 (pl) 2000-01-31
SI9300365B (sl) 2002-02-28
JPH0733791A (ja) 1995-02-03
EP0579939B1 (de) 1999-02-03

Similar Documents

Publication Publication Date Title
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
MX9304133A (es) Nuevos derivados de los fosfolipidos.
NO170331C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd

Legal Events

Date Code Title Description
GB Transfer or rights
HC Change of company name or juridical status
FG Grant or registration
HC Change of company name or juridical status